estradiol 3,17-disulfate has been researched along with Adrenal Cortex Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aichler, M; Candida Villares Fragoso, M; Fassnacht, M; Feuchtinger, A; Gill, AJ; Herterich, S; Kircher, S; Kroiss, M; Kunzke, T; Ronchi, CL; Sbiera, S; Schlegel, N; Sun, N; Walch, A; Waldmann, J; Weigand, I; Whitsett, TG | 1 |
1 other study(ies) available for estradiol 3,17-disulfate and Adrenal Cortex Cancer
Article | Year |
---|---|
Prognostic Relevance of Steroid Sulfation in Adrenocortical Carcinoma Revealed by Molecular Phenotyping Using High-Resolution Mass Spectrometry Imaging.
Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Biomarkers, Tumor; Child; Estradiol; Estrone; Female; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Prognosis; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Steroids; Sulfotransferases; Young Adult | 2019 |